Gene Expression Diagnostic For Schizophrenia And Bipolar Disorder

Schizophrenia and Bipolar Disorder are two highly prevalent disorders in the US. Diagnosis is limited to observation of clinical symptoms, often leading to under-diagnosis or misdiagnosis. It can therefore take months to years to accurately diagnose an individual and implement an effective treatment. To address this issue, researchers at UCI have identified blood based biomarkers for schizophrenia and bipolar disorder. By determining methods for evaluating expression levels of these biomarkers, they have developed a commercial test to discriminate between normal bipolar disorder and schizophrenia patients, which will allow for more efficient diagnoses. Maria Tkachuk 949-824-2288

Related Blog

Smart, interactive desk

Get ready to take your space management game to the next level with the University of Glasgow’s innovative project! By combining the

Mechanical Hamstring™

University of Delaware Technology Overview This device was created to allow athletes who suffer a hamstring strain to return to the field

Join Our Newsletter

                                                   Receive Innovation Updates, New Listing Highlights And More